Cited by 791Cancer Cells and MetastasisWnt/β-catenin signaling in development and cancerMechanisms of cancer metastasis

Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT

Open access
Malladi, Srinivas, Macalinao, Danilo G., Jin, Xin, He, Lan, Basnet, Harihar, Zou, Yilong, de Stanchina, Elisa, Massagué, Joan·2016·Cell

Abstract

Metastasis frequently develops years after the removal of a primary tumor, from a minority of disseminated cancer cells that survived as latent entities through unknown mechanisms. We isolated latency competent cancer (LCC) cells from early stage human lung and breast carcinoma cell lines and defined the mechanisms that suppress outgrowth, support long-term survival, and maintain tumor-initiating potential in these cells during the latent metastasis stage. LCC cells show stem-cell-like characteristics and express SOX2 and SOX9 transcription factors, which are essential for their survival in host organs under immune surveillance and for metastatic outgrowth under permissive conditions. Through expression of the WNT inhibitor DKK1, LCC cells self-impose a slow-cycling state with broad downregulation of ULBP ligands for NK cells and evasion of NK-cell-mediated clearance. By expressing a Sox-dependent stem-like state and actively silencing WNT signaling, LCC cells can enter quiescence and evade innate immunity to remain latent for extended periods.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cell.2016.02.025

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In vivo selection identified latency-competent cancer cells that exhibited a quiescent-like state resembling stem and progenitor cells.

    “When in vivo selection was used to identify latency-competent cancer cells, these tumors exhibited a quiescent-like state reminiscent of stem and progenitor cells (102).”

    From Metabolic reprogramming and cancer progression (2020) · cites this paper as [102]

  • In a mouse LUAD model carrying compound EgfrL858R/T790M mutations, Ctnnb1 deletion lowered tumor burden, which suggests non-redundant roles in initiating tumors.

    “in a mouse LUAD model driven by compound EgfrL858R/T790M mutations genetic deletion of Ctnnb1 reduced tumor burden indicating non-redundant functions in tumor initiation122”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Malladi, S., Macalinao, D. G., Jin, X., He, L., Basnet, H., Zou, Y., de Stanchina, E., & Massagué, J.
Affiliations
Memorial Sloan Kettering Cancer Center (US)
Corresponding author
Massagué, Joan
Venue
Cell
Publisher
Elsevier BV
Published
2016-03
Volume
165
Issue
1
Pages
45-60
ISSN
0092-8674 (ISSN-L)
OpenAlex
W2303309927
Cited by
791
References
60
Citations by year
2026: 51 · 2025: 85 · 2024: 84 · 2023: 90 · 2022: 76 · 2021: 101 · 2020: 86 · 2019: 76 · 2018: 60 · 2017: 55 · 2016: 25 · 2015: 1
FWCI
38.78
Type
journal article
Language
en
Open access
Locations
  • Cell (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Memorial Sloan Kettering Cancer Center
  • NIH (P01-CA094060, P01-CA129243, P30-CA008748)
  • DOD (W81XWH-12-1-0074)
  • American Cancer Society post-doctoral fellowship
Topics
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
Keywords
metastatic latency, immune evasion, Wnt signaling inhibition, DKK1, SOX2, SOX9, cancer stem cells, NK cell evasion, quiescence, lung cancer, breast cancer, innate immunity
MeSH terms
Animals, Breast Neoplasms, Female, Humans, Immunologic Surveillance, Killer Cells, Natural, Lung Neoplasms, Mice, Nude, Neoplasm Metastasis, Tumor Escape, Autocrine Communication, Intercellular Signaling Peptides and Proteins, Cell Line, Tumor, Mice, SOXB1 Transcription Factors, SOX9 Transcription Factor, Wnt Signaling Pathway

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review